Familial cylindromatosis

Familial cylindromatosis is caused by a harmful change in the CYLD gene.
It is usually inherited in an autosomal dominant way, so each child of an affected parent has a 50% chance to inherit it.
Less often, the change happens for the first time in a family.
Tumors often grow faster with age, puberty, or pregnancy due to hormone shifts, and these are biological risk factors for familial cylindromatosis.
Sun exposure, repeated skin irritation, and prior radiation can promote growth, and some risks are modifiable (things you can change), others are non-modifiable (things you can’t).

Genetic risk factors

In familial cylindromatosis, genetic risk is driven mainly by changes in a single tumor‑suppressor gene. Carrying a genetic change doesn’t guarantee the condition will appear. Most families inherit a faulty CYLD gene in an autosomal dominant pattern, with a 50% (1 in 2) chance of passing it to children and variable severity across relatives. Understanding the genetic causes of familial cylindromatosis can guide testing, counseling, and early skin checks.

• CYLD gene variants: Most cases are caused by loss-of-function changes in the CYLD gene, which normally helps keep cell growth signals in check. When one copy is altered in all cells, the skin is predisposed to form benign tumors. This is the primary genetic driver of familial cylindromatosis.

• Autosomal dominant inheritance: A single altered CYLD copy is enough to create risk. Each child of an affected parent has a 50% (1 in 2) chance of inheriting the variant. Severity can differ widely even within the same family.

• Two-hit mechanism: Skin tumors often arise after the remaining normal CYLD copy is lost in certain cells. This second hit explains why growths appear in some spots and increase over time. The inherited first hit sets the stage.

• Penetrance varies: Most people with a CYLD variant eventually develop skin tumors. Age at onset and number of growths vary from few to many. Exact course is hard to predict for any one person.

• De novo variants: Sometimes the CYLD change occurs for the first time in a child with no family history. Parents can test negative even when a child is affected. Recurrence risk is then usually low but not zero if one parent has undetected mosaicism.

• Genetic mosaicism: A CYLD change can be present in only a fraction of the body’s cells, causing tumors in limited or segmental areas. Mosaic cases may be milder but can still pass a typical form to children if reproductive cells carry the change. Genetic counseling can clarify this risk.

• Spectrum of syndromes: The same CYLD variants can cause related diagnoses such as Brooke‑Spiegler syndrome or multiple familial trichoepithelioma. These fall within a shared CYLD cutaneous syndrome spectrum. This explains why features can differ between relatives.

• Family history: Having a parent or sibling with a confirmed CYLD variant is a strong indicator of genetic risk. Relatives can consider targeted testing for that known variant. Early identification supports monitoring for early symptoms of familial cylindromatosis.

Transmission

Familial cylindromatosis is not contagious and cannot be caught from someone else or spread by touch, shared items, or procedures. It runs in families through a single-gene change and follows an autosomal dominant pattern, which means if a parent has familial cylindromatosis, each child has a 50% chance of inheriting it. Sometimes the genetic change happens for the first time in a child (a new or “de novo” change), so there may be no earlier family history. If you’re wondering how familial cylindromatosis is inherited, this genetic transmission affects all sexes equally and the severity can vary from one family member to another.

When to test your genes

Consider genetic testing if you have multiple scalp or skin tumors (cylindromas, spiradenomas) or a close relative with them, especially if they began young. Testing is also reasonable before surgical planning, during family planning, or if new, recurring lesions raise concern. A genetics referral helps confirm CYLD variants and tailor surveillance and treatment.

Looking at the long-term picture can be helpful. For many living with familial cylindromatosis, the condition brings recurring, skin-colored or pink bumps that grow slowly over years, most often on the scalp, face, neck, or trunk. Many people ask, “What does this mean for my future?”, and the short answer is that life expectancy is usually near normal, but the condition can affect comfort, appearance, and day-to-day routines. Tumors tend to multiply over time, and some can become tender or bleed, leading to repeated procedures. Early care can make a real difference, especially when new growths are treated while small to limit scarring and reduce the need for larger surgeries later.

Doctors call this the prognosis—a medical word for likely outcomes. Most tumors are benign for life, and the risk of cancer is low but real; transformation into a skin cancer can happen in a small minority, particularly after many years or in very large, long-standing lesions. Regular skin checks help catch changes early; warning signs include a fast-growing lump, a sore that doesn’t heal, or persistent pain in a previously quiet area. Scalp involvement can be extensive and may lead to hair loss where tumors cluster. People with familial cylindromatosis may also notice spiradenomas or trichoepitheliomas—related growths—with similar patterns over time.

With ongoing care, many people maintain active lives, balancing treatment visits with work, school, and family. Treatments are evolving: in addition to surgical removal, doctors may use lasers, destructive techniques, or, in select cases, medicines being studied to target the gene pathway. Ask about early symptoms of familial cylindromatosis that suggest a tumor is changing and what steps to take if they appear. Talk with your doctor about what your personal outlook might look like, including how often to be seen, which areas to monitor closely, and options to manage discomfort or scarring.

Treatment for familial cylindromatosis focuses on removing or shrinking skin tumors, easing symptoms, and protecting healthy skin over the long term. Most people have tumors treated with procedures such as surgical excision, laser ablation, electrosurgery, or cryotherapy; smaller growths may be managed earlier to reduce scarring and discomfort. For widespread or recurrent tumors, doctors may add medicines applied to the skin (like topical retinoids) or consider targeted options in specialist centers, and radiotherapy is generally avoided because it can increase the risk of new tumors. Treatment plans often combine several approaches, tailored to the number, size, and location of growths, as well as cosmetic concerns and pain control. Ask your doctor about the best starting point for you, and plan regular skin checks to catch early symptoms of familial cylindromatosis and decide when to treat.

Familial cylindromatosis most often stems from an inherited change in a gene called CYLD, which normally helps keep skin cell growth under control. Family history is one of the strongest clues to a genetic influence. The condition is passed in an autosomal dominant way, meaning that if a parent has the CYLD change, each child has a 50% chance of inheriting it. How strongly it shows up can vary a lot—some relatives develop just a few small bumps, while others have many growths on the scalp and face. Some people are the first in their family due to a new gene change, and in a few, the change is present in only some cells, so certain body areas are affected more than others. Growths tend to appear where skin cells lose the remaining working copy of CYLD over time, which is why new bumps can arise in patches. Genetic testing for CYLD can confirm the genetic causes of familial cylindromatosis and help relatives understand their risks and options for monitoring and treatment.

People living with Familial cylindromatosis often manage more than just the skin tumors themselves, because repeated bumps, surgeries, and scalp wounds can raise the chance of infection and slow healing, especially if diabetes or poor circulation is also present. Doctors call it a “comorbidity” when two conditions occur together, and everyday issues like acne, eczema, or chronic skin infection can complicate care by irritating already sensitive areas. When early symptoms of Familial cylindromatosis show up—small, tender bumps on the scalp or face—other skin problems may make it harder to tell which spots need removal versus simple skin care, so regular check-ins with a dermatologist matter. People who need immune‑suppressing medicines for another illness may find wounds heal more slowly and infections are harder to control after procedures. There’s also a known link with certain benign salivary gland tumors in the head and neck, so any new lumps near the jaw or ear should be assessed, and coordination with an ear, nose, and throat specialist can help. Radiation to the scalp for an unrelated cancer is generally avoided when possible, because it may trigger new growths in Familial cylindromatosis; if radiation is necessary elsewhere, your care team will tailor skin monitoring to keep you safe.

How genes can cause diseases

Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.

Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.